Paper41348830
Ultrasensitive quantification of serum IFN-α and IFN-γ in systemic lupus erythematosus: A cross-sectional observational study.
González-Gay MÁ and 13 others. PLoS Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Ultrasensitive quantification of serum IFN-α and IFN-γ in systemic lupus erythematosus: A cross-sectional observational study. Papers, record 41348830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41348830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ultrasensitive quantification of serum IFN-α and IFN-γ in systemic lupus erythematosus: A cross-sectional observational study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lupus Erythematosus, Systemic | Major topic |
| Interferon-alpha | Major topic |
| Interferon-gamma | Major topic |
| Humans | |
| Cross-Sectional Studies | |
| Female | |
| Male | |
| Adult | |
| Middle Aged | |
| Autoantibodies | |
| Biomarkers | |
| Young Adult | |
| Severity of Illness Index |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33589110 | Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus. | Med Clin North Am | 2021 | https://conductscience.org/library/papers/33589110 | PubMed |
| 2 | 33123584 | IFN-γ Mediates the Development of Systemic Lupus Erythematosus. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/33123584 | PubMed |
| 3 | 30930907 | Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations. | Front Immunol | 2019 | https://conductscience.org/library/papers/30930907 | PubMed |
| 4 | 30507062 | Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α. | Arthritis Rheumatol | 2019 | https://conductscience.org/library/papers/30507062 | PubMed |
| 5 | 25022441 | Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review. | Reumatol Clin | 2014 | https://conductscience.org/library/papers/25022441 | PubMed |
| 6 | 31570366 | Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/31570366 | PubMed |
| 7 | 8607884 | The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. | Arthritis Rheum | 1996 | https://conductscience.org/library/papers/8607884 | PubMed |
| 8 | 40097390 | Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40097390 | PubMed |
| 9 | 11838846 | Systemic lupus erythematosus disease activity index 2000. | J Rheumatol | 2002 | https://conductscience.org/library/papers/11838846 | PubMed |
| 10 | 29661791 | Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity. | Cold Spring Harb Perspect Biol | 2019 | https://conductscience.org/library/papers/29661791 | PubMed |
| 11 | 36882218 | Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. | RMD Open | 2023 | https://conductscience.org/library/papers/36882218 | PubMed |
| 12 | 10875919 | Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. | Science | 2000 | https://conductscience.org/library/papers/10875919 | PubMed |
| 13 | 30626657 | Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/30626657 | PubMed |
| 14 | 32884126 | New insights into the role of antinuclear antibodies in systemic lupus erythematosus. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/32884126 | PubMed |
| 15 | 36863752 | Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. | RMD Open | 2023 | https://conductscience.org/library/papers/36863752 | PubMed |
| 16 | 38876981 | Plasma interferon-alpha protein levels during pregnancy are associated with lower birth weight in systemic lupus erythematosus. | Rheumatology (Oxford) | 2025 | https://conductscience.org/library/papers/38876981 | PubMed |
| 17 | 27088255 | Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/27088255 | PubMed |
| 18 | 38622070 | Unique Interplay Between Antinuclear Antibodies and Nuclear Molecules in the Pathogenesis of Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2024 | https://conductscience.org/library/papers/38622070 | PubMed |
| 19 | 36555640 | Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555640 | PubMed |
| 20 | 9883317 | Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity. | Arch Immunol Ther Exp (Warsz) | 1998 | https://conductscience.org/library/papers/9883317 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972592 | Defining the optimal interferon-stimulated genes panel to reflect serum interferon-α levels in patients with systemic lupus erythematosus. | BMC Med | 2026 | https://conductscience.org/library/papers/42972592 | PubMed |
| 42621162 | Ultrasensitive serum interferon alpha equals interferon signatures as a marker of lupus disease activity. | iScience | 2026 | https://conductscience.org/library/papers/42621162 | PubMed |
| 42046569 | Application Value of Blood Routine-Derived Indices for the Evaluation of Disease Activity in Systemic Lupus Erythematosus. | Clin Med Insights Arthritis Musculoskelet Disord | 2026 | https://conductscience.org/library/papers/42046569 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41348830
GET https://conductscience.org/api/papers/v1/41348830/references?page=2